Goldman Sachs Group »

Immix Biopharma shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.1M 208k 5.23

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Spdr S&p 500 Etf Tr CMN (SPY)
Tesla CMN (TSLA)
Alphabet CMN (GOOGL)
Amazon CMN (AMZN)
Broadcom CMN (AVGO)
Meta Platforms CMN (META)
Invesco Qqq Tr CMN (QQQ)
Vanguard Index Fds CMN (VOO)
Alphabet CMN (GOOG)
Ishares Tr CMN (IVV)
Eli Lilly & Co CMN (LLY)
Jpmorgan Chase & Co. CMN (JPM)

View all positions for Goldman Sachs Group

Top funds holding Immix Biopharma

Marshall Wace
Vanguard Group
Logos Global Management
Franklin Resources
Bleichroeder
Renaissance Technologies
Geode Capital Management
KVP Capital Advisors
Goldman Sachs Group
Eudaimonia Asset Management
Bank of New York Mellon
State Street Corporation
Susquehanna International
Citadel Advisors
Northern Trust

View all funds holding Immix Biopharma